Skip To Main Content
Campus
  • Utbildning
  • Artiklar
Campus
  • Utbildning
  • Artiklar
View Full Results
Sort by

Filtera

Återställ
  • Filtera
  • Innehållstyp
Pain and GI symptoms management

Pain and GI symptoms management

Läs mer
Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?<sup>1</sup>

Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?

Summary of Zoungas S, et al. Diabetologia. 2012;55:636–643.

Läs mer
Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Enhancing quality and improving outcomes: patient-first approach in Fabry disease

Läs mer
Approach for patients with coronary artery disease (CAD): focus on LDL-C control

Approach for patients with coronary artery disease (CAD): focus on LDL-C control

Läs mer
Chronic Kidney Disease

Chronic Kidney Disease

Management in Patients with Fabry Disease.

Läs mer
Interview with Prof. Thaçi: Longterm Control in Atopic Dermatitis

Interview with Prof. Thaçi: Longterm Control in Atopic Dermatitis

Läs mer
When to Initiate Basal Insulin?

When to Initiate Basal Insulin?

Practical Guidance based on the 2022 ADA/EASD Guidelines.

Läs mer
Approach for patients with peripheral artery disease (PAD) + T2DM: focus on LDL-C control

Approach for patients with peripheral artery disease (PAD) + T2DM: focus on LDL-C control

Läs mer
Cardiovascular diseases (CVDs) are the leading cause of death globally<sup>1</sup>

Cardiovascular diseases (CVDs) are the leading cause of death globally

Läs mer
What is PRALUENT<sup>®</sup>(alirocumab)?

What is PRALUENT®(alirocumab)?

PRALUENT®: a PCSK9i that ticks all the boxes1–4

 

PRALUENT is a PCSK9i that reduces the levels of LDL-C in the blood.2 It is a fully human IgG1 monoclonal antibody that works by inhibiting the binding of PCSK9 to LDL- receptors. As a result, PRALUENT increases the number of LDL-receptors available to clear LDL, thereby lowering LDL-C levels.2 Elevated LDL-C levels have been significantly associated with cardiovascular disease such as heart attacks and strokes.1

Läs mer
Polyp Gossip – Episode 1

Polyp Gossip – Episode 1: Surgical Whispers: Is One Surgery Enough Before Starting Biologics?

Welcome to the debut episode of Polyp Gossip! In this episode, our expert panel explores a critical question in CRSwNP management: Is one surgery enough before starting biologics?

Läs mer
Polyp Gossip – Episode 2

Polyp Gossip – Episode 2: Scent-sational Secrets: The Smell Loss Truth

We explore the impact of smell impairment and its connection to CRSwNP. Featuring insights from our hosts and a special guest, we uncover pathways to recovery and improved quality of life.

Läs mer